SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENSET - GENXY -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (163)3/1/2001 11:41:22 AM
From: keokalani'nui  Respond to of 200
 
Yeah, well, can ValiGen expect the same productivity in 'the discovery and development of the next generation of human therapeutics' Dr. Bihain achieved at genxy?

Is Goldman interested in take-out fee? Surprising, as at this rate it would only be a few million.

--Wilder



To: nigel bates who wrote (163)3/1/2001 11:23:08 PM
From: Mike McFarland  Read Replies (1) | Respond to of 200
 
<...the next generation of human therapeutics>

What a frustrating game for investors--if the next
generation
is always more interesting. If biotech
startups are only good for a few years til the next
round of startups emerges, with a new set of IPOs, burn,
repeat. And all that expensive great science--Genset's
SNP map, rendered mostly obsolete (?) by the Wellcome
trust, a protein library, nah, large scale proteomics
man! etc etc

So now maybe some new companies, Valigen for one--they
turn up the sex appeal, and sure, they do some great
science, they get their IPO, and then what. Five years
from now they pull a Genset.

Or the whole thing is phoney. If I have shares at $12
somebody else out there might as well get his at $6.

This is cute...my little daughter is tearing up my
special Nature, the Genome issue, heheh. Oh heck,
I tucked enough away that she is going to any school
she wants to many years from now, what is it to me
if the stocks I chose to keep are stinkers. I am
still the luckiest man I know, so goodnight everybody.
Best wishes finding the next hot stock. It ain't easy.